Bionomics Limited (BNOX)
0.2531
+0.0110 (4.59%)
Inactive · Last trade price
on Dec 23, 2024
Bionomics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Operating Revenue | - | - | 0.26 | - | 0.05 | Upgrade
|
| Other Revenue | - | - | 5.79 | 0.93 | 2.95 | Upgrade
|
| Revenue | - | - | 6.06 | 0.93 | 2.99 | Upgrade
|
| Revenue Growth (YoY) | - | - | 552.46% | -68.98% | -59.37% | Upgrade
|
| Cost of Revenue | - | - | 16 | 5.76 | 5.83 | Upgrade
|
| Gross Profit | - | - | -9.94 | -4.83 | -2.84 | Upgrade
|
| Selling, General & Admin | 8.47 | 8.91 | 7.66 | 5.65 | 4.85 | Upgrade
|
| Research & Development | 9.32 | 12.65 | - | - | - | Upgrade
|
| Other Operating Expenses | - | - | -0.01 | -0.2 | -0.2 | Upgrade
|
| Operating Expenses | 17.8 | 21.56 | 7.65 | 5.44 | 4.65 | Upgrade
|
| Operating Income | -17.8 | -21.56 | -17.6 | -10.28 | -7.49 | Upgrade
|
| Interest Expense | - | - | -0.03 | -1.43 | -1.82 | Upgrade
|
| Interest & Investment Income | 0.22 | 0.32 | 0.01 | 0.01 | 0.06 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.21 | 0.31 | 0.36 | 1.08 | -0.62 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | -3.75 | -1.63 | -1.46 | Upgrade
|
| EBT Excluding Unusual Items | -17.79 | -20.93 | -21.01 | -12.25 | -11.33 | Upgrade
|
| Gain (Loss) on Sale of Investments | 2.21 | -0.59 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0 | -0.02 | 0.17 | Upgrade
|
| Other Unusual Items | - | - | -0.94 | 3.38 | 5.13 | Upgrade
|
| Pretax Income | -15.58 | -21.52 | -21.95 | -8.88 | -6.03 | Upgrade
|
| Income Tax Expense | -0.09 | -0.14 | -0.19 | -0.19 | -0.21 | Upgrade
|
| Earnings From Continuing Operations | -15.49 | -21.38 | -21.76 | -8.7 | -5.82 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | -1.3 | Upgrade
|
| Net Income | -15.49 | -21.38 | -21.76 | -8.7 | -7.12 | Upgrade
|
| Net Income to Common | -15.49 | -21.38 | -21.76 | -8.7 | -7.12 | Upgrade
|
| Shares Outstanding (Basic) | 10 | 8 | 8 | 4 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 8 | 8 | 4 | 3 | Upgrade
|
| Shares Change (YoY) | 22.39% | 8.53% | 73.52% | 43.14% | 4.52% | Upgrade
|
| EPS (Basic) | -1.55 | -2.62 | -2.89 | -2.01 | -2.35 | Upgrade
|
| EPS (Diluted) | -1.55 | -2.62 | -3.60 | -2.01 | -2.35 | Upgrade
|
| Free Cash Flow | -14.68 | -14.64 | -21.76 | -7.54 | -3.91 | Upgrade
|
| Free Cash Flow Per Share | -1.47 | -1.79 | -2.89 | -1.74 | -1.29 | Upgrade
|
| Gross Margin | - | - | -164.21% | - | -94.76% | Upgrade
|
| Operating Margin | - | - | -290.62% | -1107.29% | -250.19% | Upgrade
|
| Profit Margin | - | - | -359.34% | -937.11% | -237.89% | Upgrade
|
| Free Cash Flow Margin | - | - | -359.30% | -812.46% | -130.70% | Upgrade
|
| EBITDA | -17.35 | -21.23 | -16.67 | -9.34 | -6.07 | Upgrade
|
| EBITDA Margin | - | - | -275.36% | - | -202.73% | Upgrade
|
| D&A For EBITDA | 0.45 | 0.33 | 0.92 | 0.94 | 1.42 | Upgrade
|
| EBIT | -17.8 | -21.56 | -17.6 | -10.28 | -7.49 | Upgrade
|
| EBIT Margin | - | - | -290.62% | - | -250.19% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.